ID   NZM077
AC   CVCL_0D40
SY   NZM77
DR   BioSample; SAMN14558349
DR   cancercelllines; CVCL_0D40
DR   Wikidata; Q54931618
RX   PubMed=32567790;
CC   HLA typing: A*01:01,03:01; B*08:01,15:01; C*03:03,07:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Pro1323Ser (c.3967C>T); ClinVar=VCV000945186; Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,18
ST   D19S433: 13,14.2
ST   D21S11: 26,30
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 18,22
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
RX   PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249;
RA   Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J.,
RA   Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S.,
RA   Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.;
RT   "Genomic and signalling pathway characterization of the NZM panel of
RT   melanoma cell lines: a valuable model for studying the impact of
RT   genetic diversity in melanoma.";
RL   Pigment Cell Melanoma Res. 34:136-143(2021).
//